Carmell Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: Pittsburgh PA United States (2007)

Organization Overview

First Clinical Trial
2019
NCT03826784
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Carmell Therapeutics | Carmell Therapeutics Corporation